Penicillin-binding proteins: Evergreen drug targets

Current Opinion in Pharmacology

Volumn 18, Issue , 2014, Pages 112-119

  Frère, Jean Marie ^a   Page, Malcolm G P ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AVIBACTAM; BETA LACTAM ANTIBIOTIC; CEFTOBIPROLE; GAMMA GLUTAMYLTRANSFERASE; PENICILLIN BINDING PROTEIN; ANTIINFECTIVE AGENT; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOSYNTHESIS; CELL WALL; DRUG TARGETING; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; NONHUMAN; PROTEIN STRUCTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; METABOLISM; PENICILLIN RESISTANCE; PHYSIOLOGY; PROTEIN CONFORMATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PROTEIN CONFORMATION;

EID: 84908279514     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.09.012     Document Type: Review

References (95)

1. Page MGP: Resistance mediated by penicillin-binding proteins. In Enzyme Mediated Resistance to Antibiotics. Mechanisms, Dissemination and Prospects for Inhibition. Edited by Bonom RA, Tolmasky M. Washington: ASM Press; 2007:81-99.
2. Zapun A, Contreras-Martel C, Vernet T: Penicillin-binding proteins and β-lactam resistance. FEMS Microbiol Rev 2008, 32:361-385.
3. Page MGP, Bush K: Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising? Curr Opin Pharmacol 2014. (in this issue).
4. Martin HH: Composition of the mucopolymer in cell walls of the unstable and stable L-form of Proteus mirabilis. J Gen Microbiol 1964, 36:441-450.
5. Wise EM, Park JT: Penicillin: its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis. Proc Natl Acad Sci U S A 1965, 54:75-81.
6. Tipper DJ, Strominger JL: Mechanism of action of penicillins: a proposal based on their structural similarity to acyl- D-alanyl- D-alanine. Proc Natl Acad Sci U S A 1965, 54:1133-1141.
7. Yocum RR, Blumberg PM, Strominger JL: Purification and characterization of the thermophilic D-alanine carboxypeptidase from membranes of Bacillus stearothermophilus. J Biol Chem 1974, 249:4863-4870.
8. Pollock JJ, Ghuysen JM, Linder R, Salton MRJ, Perkins HR, Nieto M, Leyh-Bouille M, Frère JM, Johnson K: Transpeptidase activity of Streptomyces D-alanyl-D carboxypeptidases. Proc Natl Acad Sci U S A 1972, 69:662-666.
9. Leyh-Bouille M, Nakel M, Frère JM, Johnson K, Ghuysen JM, Nieto M, Perkins HR: Penicillin-sensitive DDcarboxypeptidases from Streptomyces strains R39 and K11. Biochemistry 1972, 11:1290-1298.
10. Ghuysen M, Leyh-Bouille M, Campbell JN, Moreno R, Frère JM, Duez C, Nieto M, Perkins HR: The structure of the wall peptidoglycan of Streptomyces R39 and the specificity profile of its exocellular DD-carboxypeptidase-transpeptidase for peptide acceptors. Biochemistry 1973, 12:1243-1251.
11. Zeiger AR, Frère JM, Ghuysen JM, Perkins HR: A donor-acceptor substrate of the exocellular DD-carboxypeptidase- transpeptidase from Streptomyces R61. FEBS Lett 1975, 52:221-225.
12. Frère JM, Ghuysen JM, Zeiger AR, Perkins HR: The direction of peptide trimer synthesis from the donor-acceptor substrate Na-(acetyl)-Nε-(glycyl)-L-Lysyl- D-alanyl-D-alanine by the exocellular DD-carboxy-peptidase-transpeptidase of Streptomyces R61. FEBS Lett 1976, 63:112-116.
13. Frère JM, Ghuysen JM, Iwatsubo M: Kinetics of interaction between the exocellular DD-carboxypeptidase- transpeptidase from Streptomyces R61 and β-lactam antibiotics. A choice of models. Eur J Biochem 1975, 57:343-351.
14. Fuad N, Frère JM, Duez C, Ghuysen JM, Iwatsubo M: Mode of interaction between β-lactam antibiotics and the exocellular DD-carboxypeptidase-transpeptidase from Streptomyces R39. Biochem J 1976, 155:626-629.
15. Degelaen J, Feeney J, Roberts GCK, Burgen ASV, Frère JM, Ghuysen JM: NMR evidence for the structure of the complex between penicillin and the DD-carboxypeptidase of Streptomyces R61. FEBS Lett 1979, 98:53-56.
16. Frère JM, Ghuysen JM, Degelaen J, Loffet A, Perkins HR: Fragmentation of benzyl penicillin after interaction with the exocellular DD-carboxypeptidases-transpeptidases of Streptomyces R61 and R39. Nature 1975, 258:168-170.
17. Frère JM, Ghuysen JM, Vanderhaeghe H, Adriaens P, Degelaen J, De Graeve J: The fate of the thiazolidine ring during fragmentation of penicillin by the exocellular DD-carboxypeptidase-transpeptidase of Streptomyces R61. Nature 1976, 260:451-454.
18. Hammarström S, Strominger JL: Degradation of penicillin G to phenylacetylglycine by D-alanine carboxypeptidase from Bacillus stearothermophilus. Proc Natl Acad Sci U S A 1975, 72:3463-3467.
19. Varetto L, Frère JM, Ngyen-Distèche M, Ghuysen JM, Houssier C: The pH dependence of the active-site serine DD-peptidase of Streptomyces R61. Eur J Biochem 1987, 162:525-531.
20. 14C]phenylacetylglycine. J Biol Chem 1979, 254 :12056-12061.
21. Frère JM, Joris B: Penicillin-sensitive enzymes in peptidoglycan biosynthesis. CRC Crit Rev Microbiol 1985, 11:299-396.
22. Frère JM, Nguyen-Distèche M, Coyette J, Joris B: Mode of action: interactions with the penicillin-binding proteins. In The Chemistry of β-Lactams. Edited by Page M. Andover, England: Chapman & Hall Ltd.; 1992:148-197.
23. Frère JM, Duez C, Ghuysen JM, Vandekerckhove J: Occurrence of a serine residue in the penicillin-binding site of the exocellular DD-carboxypeptidase-transpeptidase from Streptomyces R61. FEBS Lett 1976, 70 :257-260.
24. Yocum RR, Amanuma H, O'Brien TA, Waxman DJ, Strominger JL: Penicillin is an active-site inhibitor for four genera of bacteria. J Bacteriol 1982, 149:1150-1153.
25. Spratt BG: Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proc Natl Acad Sci U S A 1975, 72:2999-3003.
26. van Heijenoort J: Peptidoglycan hydrolases of Escherichia coli. Microbiol Mol Biol Rev 2011, 75:636-663.
27. Banzhaf M, van den Berg van Saparoea B, Terrak M, Fraipont C, Egan A, Philippe J, Zapun A, Breukink E, Nguyen-Distèche M, den Blaauwen T, Vollmer W: Cooperativity of peptidoglycan synthases active in bacterial cell elongation. Mol Microbiol 2012, 85:179-194.
28. Bertsche U, Kast T, Wolf B, Fraipont C, Aarsman ME, Kannenberg K, von Rechenberg M, Nguyen-Distèche M, van Blaauwen T, Höltje JV, Vollmer W: Interaction between two murein (peptidoglycan) synthases, PBP3 and PBP1B, in Escherichia coli. Mol Microbiol 2006, 61:675-690.
29. Goffin C, Ghuysen JM: Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev 1998, 62:1079-1093.
30. Zhu Y, Englebert S, Joris B, Ghuysen JM, Kobayashi T, Lampen JO: Structure, function, and fate of the BlaR signal transducer involved in induction of beta-lactamase in Bacillus licheniformis. J Bacteriol 1992, 174:6171-6178.
31. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P: The penicillinbinding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 2008, 32:234-258. Comprehensive review of the structure and function of penicillin binding proteins.
32. Kelly JA, Moews PC, Knox JR, Frère JM, Ghuysen JM: Structure of a penicillin target enzyme and location of the antibiotic binding site. Science 1982, 218:479-480.
33. Kelly JA, Knox JR, Moews PC, Hite GJ, Bartolone JB, Zhao H, Joris B, Frère JM, Ghuysen JM: 2.8 A˚ structure of penicillin-sensitive D-alanyl carboxypeptidase-transpeptidase from Streptomyces R61 and complexes with β-lactams. J Biol Chem 1985, 260:6449-6458.
34. Kelly JA, Dideberg O, Charlier P, Wéry JP, Libert M, Moews PC, Knox JR, Duez C, Fraipont C, Joris B, Dusart J, Frère JM, Ghuysen JM: On the origin of bacterial resistance to penicillin. Comparison of an active-site serine β-lactamase and an active-site serine D-alanyl-D-alanine-cleaving peptidase. Science 1986, 231:1429-1431.
35. Samraoui B, Sutton BJ, Todd RJ, Arymiuk PJ, Waley SG, Phillips DC: Tertiary structural similarity between a class A beta-lactamase and a penicillin-sensitive D-alanyl carboxypeptidase-transpeptidase. Nature 1986, 320 :378-380.
36. Charlier P, Ghuysen JM, Frère JM: Zinc D-Ala-D-Ala carboxypeptidase (Streptomyces). In Handbook of Proteolytic Enzymes, edn 3. Edited by Barrett AJ, Rawlings ND, Woessner JF.London: Elsevier Academic Press; 2012. (Chapter 312).
37. Pratt RF, Frère JM: Streptomyces R61 D-Ala-D-Ala carboxypeptidase. In Handbook of Proteolytic Enzymes, edn 3. Edited by Barrett AJ, Rawlings ND, Woessner JF.London: Elsevier Academic Press; 2012. (Chapter 766).
38. Sauvage E, Frère JM: Actinomadura R39 D-Ala-D-Ala carboxypeptidase. In Handbook of Proteolytic Enzymes, edn 3. Edited by Barrett AJ, Rawlings ND, Woessner JF.London: Elsevier Academic Press; 2012. (Chapter 771).
39. Sauvage E, Herman R, Petrella S, Duez C, Bouillenne F, Frère JM, Charlier P: Crystal structure of the Actinomadura R39 DDpeptidase reveals new domains in penicillin-binding protein. J Biol Chem 2005, 280:31249-31256.
40. Kishida H, Unzai S, Roper DI, Lloyd A, Park SY, Tame JR: Crystal structure of penicillin binding protein 4 (dacB) from Escherichia coli, both in the native form and covalently linked to various antibiotics. Biochemistry 2006, 45:783-792.
41. Sauvage E, Duez C, Herman R, Kerff F, Petrella S, Anderson JW, Adediran SA, Pratt RF, Frère JM, Charlier P: Crystal structure of the Bacilllus subtilis penicillin-binding protein 4a, and its complex with a peptidoglycan mimetic peptide. J Mol Biol 2007, 371:528-539.
42. Kawai F, Clarke TB, Roper DI, Han GJ, Hwang KY, Unzai S, Obayashi E, Park SY, Tame JR: Crystal structures of penicillin- binding proteins 4 and 5 from Haemophilus influenzae. J Mol Biol 2010, 396:634-645.
43. Nicola G, Tomberg J, Pratt RF, Nicholas RA, Davies C: Crystal structures of covalent complexes of beta-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity. Biochemistry 2010, 49:8094-8104.
44. Lebar MD, Lupoli TJ, Tsukamoto H, May JM, Walker S, Kahne D: Forming cross-linked peptidoglycan from synthetic gramnegative Lipid II. J Am Chem Soc 2013, 135:4632-4635.
45. Bertsche U, Breukink E, Kast T, Vollmer W: In vitro murein peptidoglycan synthesis by dimers of the bifunctional transglycosylase-transpeptidase PBP1B from Escherichia coli. J Biol Chem 2005, 280:38096-38101.
46. Born P, Breukink E, Vollmer W: In vitro synthesis of cross-linked murein and its attachment to sacculi by PBP1A from Escherichia coli. J Biol Chem 2006, 281:26985-26993.
47. Adam M, Damblon C, Jamin M, Zorzi W, Dusart V, Galleni M, El Kharroubi A, Piras G, Spratt BG, Keck W, Coyette J, Ghuysen JM, Nguyen-Distèche M, Frère JM: Acyltransferase activities of the high-molecular-mass essential penicillin-binding proteins. Biochem J 1991, 279 :601-604.
48. Jamin M, Damblon C, Millier S, Hakenbeck R, Frère JM: Penicillin-binding protein 2x of Streptococcus pneumoniae: enzymic activities and interactions with β-lactams. Biochem J 1993, 292:735-741.
49. Zawadzka-Skomia J, Markiewics Z, Nguyen-Distèche M, Devreese B, Frère JM, Terrak M: Characterisation of the bifunctional glycosyltransferase/acyltransferase penicillinbinding protein 4 of Listeria monocytogenes. J Bacteriol 2006, 188:1875-1881.
50. Pagliero E, Chesnel L, Hopkins J, Croizé J, Dideberg O, Vernet T, Di Guilmi AM: Biochemical characterization of Streptococcus pneumonie penicillin-binding protein 2b and its implication in beta-lactam resistance. Antimicrob Agents Chemother 2004, 48:1848-1855.
51. Chittock RS, Ward S, Wilkinson AS, Caspers P, Mensch B, Page MGP, Wharton CW: Hydrogen bonding and protein perturbation in β-lactam acyl-enzymes of Streptococcus pneumoniae penicillin binding protein PBP2x. Biochem J 1999, 338:153-159.
52. Yamachika S, Sugihara C, Kamai Y, Yamashita M: Correlation between penicillin-binding protein 2 mutations and carbapenem resistance in Escherichia coli. J Med Microbiol 2013, 62:429-436.
53. Thomas B, Wang Y, Stein RL: Kinetic and mechanistic studies of penicillin-binding protein 2x from Streptococcus pneumoniae. Biochemistry 2001, 40:15811-15823.
54. Lu WP, Kincaid E, Sun Y, Bauer MD: Kinetics of β-lactam interactions with penicillin-susceptible and -resistant penicillin binding protein 2x proteins from Streptococcus pneumoniae. Involvement of acylation and deacylation in β-lactam resistance. J Biol Chem 2001, 276:31494-31501.
55. Zorzi W, Zhou XY, Dardenne O, Lamotte J, Raze D, Pierre J, Gutmann L, Coyette J: Structure of the low affinity penicillin- binding protein 5 PBP5fm in wild type and highly resistant strains of Enterococcus faecium. J Bacteriol 1996, 178 :4948-4957.
56. Graves-Woodward K, Pratt RF: Reaction of soluble penicillin- binding protein 2a of methicillin-resistant Staphylococcus aureus with β-lactams and acyclic substrates: kinetics in homogeneous solution. Biochem J 1998, 332:755-761.
57. Henry X, Amoroso A, Coyette J, Joris B: Interaction of ceftobiprole with the low-affinity PBP5 of Enterococcus faecium. Antimicrob Agents Chemother 2010, 54:953-955.
58. Fuda C, Suvorov M, Vakulenko SB, Mobashery S: The basis for resistance to beta-lactam antibiotics by penicillin binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem 2004, 279:40802-40806.
59. Ligozzi M, Pittaluga F, Fontana R: Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1996, 40:354-357.
60. Rybkine T, Mainardi JL, Sougakoff W, Collatz E, Gutmann L: Penicillin binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of β-lactam resistance. J Infect Dis 1998, 178:159-163.
61. Rice LB, Bellais S, Carias LL, Hutton-Thomas R, Bonomo RA, Caspers P, Page MG, Gutmann L: Impact of specific mutations on expression of β-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004, 48:3028-3032.
62. Katayama Y, Zhang HZ, Chambers HF: PBP2a mutations producing very high-level resistance to beta-lactams. Antimicrob Agents Chemother 2004, 48:453-459.
63. Banerjee R, Gretes M, Basuino L, Strynadka N, Chambers HF: In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008, 52 :2089-2096.
64. Mendes RE, Tsakris A, Sader HS, Jones RN, Biek D, McGhee P, Appelbaum PC, Kosowska-Shick K: Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. J Antimicrob Chemother 2012, 67:1321-1324.
65. Jones RN, Mendes RE, Sader HS: Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. J Antimicrob Chemother 2010, 65(Suppl 4):iv17-iv31.
66. Alm RA, McLaughlin RE, Kos VN, Sader HS, Iaconis JP, Lahiri SD: Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective. J Antimicrob Chemother 2014, 69:2065-2075.
67. Hujer AM, Kania M, Gerken T, Anderson VE, Buynak J, Ge X, Caspers P, Page MGP, Rice LB, Bonomo RA: Structure-activity relationships of different β-lactam antibiotics against a soluble form of Enterococcus faecium PBP5, a type II bacterial transpeptidase. Antimicrob Agents Chemother 2005, 49:612-618.
68. Yoshida H, Kawai F, Obayashi E, Akashi S, Roper DI, Tame JR, Park SY: Crystal structures of penicillin-binding protein 3 (PBP3) from methicillin-resistant Staphylococcus aureus in the apo and cefotaxime-bound forms. J Mol Biol 2012, 423 :351-364.
69. Macheboeuf P, Lemaire D, Teller N, Martins Ados S, Luxen A, Dideberg O, Jamin M, Dessen A: Trapping of an acyl-enzyme intermediate in a penicillin-binding protein (PBP)-catalyzed reaction. J Mol Biol 2008, 376:405-413.
70. Yamada M, Watanabe T, Miyara T, Baba N, Saito J, Takeuchi Y, Ohsawa F: Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity. Antimicrob Agents Chemother 2007, 51 :3902-3907.
71. Yamada M, Watanabe T, Baba N, Takeuchi Y, Ohsawa F, Gomi S: Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae. Antimicrob Agents Chemother 2008, 52:2053-2060.
72. Sainsbury S, Bird L, Rao V, Shepherd SM, Stuart DI, Hunter WN, Owens RJ, Ren J: Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa : comparison of native and antibiotic-bound forms. J Mol Biol 2011, 405:173-184.
73. Sauvage E, Derouaux A, Fraipont C, Joris M, Herman R, Rocaboy M, Schloesser M, Dumas J, Kerff F, Nguyen-Distèche M, Charlier P: Crystal structure of penicillin-binding protein 3 (PBP3) from Escherichia coli. PLOS ONE 2014, 9:e98042.
74. Sung MT, Lai YT, Huang CY, Chou LY, Shih HW, Cheng WC, Wong CH, Ma C: Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proc Natl Acad Sci U S A 2009, 106:8824-8829.
75. Job V, Carapito R, Vernet T, Dessen A, Zapun A: Common alterations in PBP1a from resistant Streptococcus pneumoniae decrease its reactivity toward beta-lactams: structural insights. J Biol Chem 2008, 283:4886-4894.
76. Maurer P, Koch B, Zerfass I, Krauss J, van der Linden M, Frère JM, Contreras-Martel C, Hakenbeck R: Penicillin-binding protein 2x of Streptococcus pneumoniae : three new mutational pathways for remodelling an essential enzyme into a resistance determinant. J Mol Biol 2008, 376:1403-1416.
77. Contreras-Martel C, Dahout-Gonzalez C, Martins Ados S, Kotnik M, Dessen A: PBP active site flexibility as the key mechanism for beta-lactam resistance in pneumococci. J Mol Biol 2009, 387:899-909.
78. Powell AJ, Tomberg J, Deacon AM, Nicholas RA, Davies C: Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance. J Biol Chem 2009, 284:1202-1212.
79. Lim D, Strynadka NCJ: Structural basis for the β-lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol 2002, 9:870-876.
80. Sauvage E, Kerff F, Fonze E, Herman R, Schoot B, Marquette JP, Taburet Y, Prevost D, Dumas J, Leonard G, Stefanic, Coyette J, Charlier P: The 2.4 A˚ crystal structure of the penicillin resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin. Cell Mol life Sci 2002, 59:1223-1230.
81. Lovering AL, Gretes MC, Safadi SS, Danel F, De Castro L, Page MGP, Strynadka NCJ: Structural insights into the anti-methicillin- resistant Staphylococcus aureus (MRSA) activity of ceftobiprole. J Biol Chem 2013, 287:32096-32102.
82. Otero LH, Rojas-Altuve A, Llarull LI, Carrasco-López C, Kumararsiri M, Lastochkin E, Fishovitz J, Dawley M, Hesek D, Lee M, Johnson JW, Fisher JF, Chang M, Mobashery S, Hermoso JA: How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc Natl Acad Sci U S A 2013, 110:16808-16813.
83. Henry X, Verlaine O, Amoroso A, Coyette J, Frère JM, Joris B: Activity of ceftaroline against Enterococcus faecium PBP5. Antimicrob Agents Chemother 2013, 57:6358-6360.
84. Fishovitz J, Rojas-Altuve A, Otero LH, Dawley M, Carrasco- López C, Chang M, Hermoso JA, Mobashery S: Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics. J Am Chem Soc 2014, 136:9814-9817.
85. Macheboeuf P, Fischer DS, Brown T Jr, Zervosen A, Luxen A, Joris B, Dessen A, Schofield CJ: Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins. Nat Chem Biol 2007, 3:565-569.
86. Starr J, Brown MF, Aschenbrenner L, Caspers N, Che Y, Gerstenberger BS, Huband M, Knafels JD, Lemmon MM, Li C, McCurdy SP, McElroy E, Rauckhorst MR, Tomaras AP, Young JA, Zaniewski RP, Shanmugasundaram V, Han S: Siderophore receptor-mediated uptake of lactivicin analogues in Gram- Negative bacteria. J Med Chem 2014, 57:3845-3850.
87. Asli A, Brouillette E, Malouin F: Binding of avibactam to penicillin-binding proteins (PBPs) of Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae. Poster P1564, 24th ECCMID; 13-15 May, Barcelona, Spain: 2014.
88. Pechenov A, Stefanova ME, Nicholas RA, Peddi S, Gutheil WG: Potential transition state analogue inhibitors for the penicillinbinding proteins. Biochemistry 2003, 42 :579-588.
89. Contreras-Martel C, Amoroso A, Woon EC, Zervosen A, Inglis S, Martins A, Verlaine O, Rydzik AM, Job V, Luxen A, Joris B, Schofield CJ, Dessen A: Structure-guided design of cell wall biosynthesis inhibitors that overcome β-lactam resistance in Staphylococcus aureus (MRSA). ACS Chem Biol 2011, 6:943-951.
90. Dzhekieva L, Kumar I, Pratt RF: Inhibition of bacterial DD-peptidases (penicillin-binding proteins) in membranes and in vivo by peptidoglycan-mimetic boronic acids. Biochemistry 2012, 51:2804-2811.
91. Zervosen A, Bouillez A, Herman A, Amoroso A, Joris B, Sauvage E, Charlier P, Luxen A: Synthesis and evaluation of boronic acids as inhibitors of penicillin binding proteins of classes A, B and C. Bioorg Med Chem 2012, 20:3915-3924.
92. Zervosen A, Lu WP, Chen Z, White RE, Demuth TP, Frère JM: Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones. Antimicrob Agents Chemother 2004, 48:961-969.
93. Turk S, Verlaine O, Gerards T, Zivec M, Humljan J, Sosič I, Amoroso A, Zervosen A, Luxen A, Joris B, Gobec S: New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria. PLoS ONE 2011, 6:e19418.
94. Sosič I, Turk S, Sinreih M, Trošt N, Verlaine O, Amoroso A, Zervosen A, Luxen A, Joris B, Gobec S: Exploration of the chemical space of novel naphthalene-sulfonamide and anthranilic acid-based inhibitors of penicillin-binding proteins. Acta Chim Slov 2012, 59:280-388.
95. O'Daniel PI, Peng Z, Pi H, Testero SA, Ding D, Spink E, Leemans E, Boudreau MA, Yamaguchi T, Schroeder VA, Wolter WR, Llarrull LI, Song W, Lastochkin E, Kumarasiri M, Antunes NT, Espahbodi M, Lichtenwalter K, Suckow MA, Vakulenko S, Mobashery S, Chang M: Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with gram-positive antibacterial activity. J Am Chem Soc 2014, 136:3664-3672.